A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment. (2017)

• Record Type: Journal Article
• Authors: Moriya, Keiichi; Tamura, Hideto; Nakamura, Kyoko; Hosone, Masaru; Inokuchi, Koiti
• Is Part Of: Leukemia research reports. Volume 7(2017)
• Page Start: 2
• Page End: 5
• Publication Date: 2017
• Subjects: Esophageal lymphoma -- Helicobacter pylori -- Eradication therapy -- MALT lymphoma; Leukemia -- Periodicals; Lymphomas -- Periodicals; Multiple myeloma -- Periodicals; Leukemia -- Periodicals; Lymphoma -- Periodicals; Multiple Myeloma -- Periodicals; Hematologic Neoplasms -- Periodicals; Leukemia; Lymphomas; Multiple myeloma; Electronic journals; Periodicals; 616.9941905
• DOI: 10.1016/j.lrr.2016.12.001
• Languages: English
• ISSNs: 2213-0489

Abstract

Abstract: Primary esophageal lymphoma is an extremely rare disease. We report a 76-year-old woman with esophageal lymphoma who achieved remission after Helicobacter pylori (HP) eradication. Esophagogastroduodenoscopy (EGD) revealed a mass in the lower esophagus, and she was diagnosed with stage IE mucosa-associated lymphoid tissue (MALT) lymphoma. She rejected any anti-lymphoma treatment except for HP eradication. Follow-up EGD demonstrated the disappearance of the esophageal MALT lymphoma 2 months after HP eradication, and she remained in remission for more than 3 years. Our results demonstrate that HP eradication may be effective as initial therapy in primary esophageal MALT lymphoma patients with HP infection.